156 related articles for article (PubMed ID: 21554263)
1. Targeting cell surface β2 -microglobulin by pentameric IgM antibodies.
Cao Y; Lan Y; Qian J; Zheng Y; Hong S; Li H; Wang M; Kwak LW; Lin D; Yang J; Yi Q
Br J Haematol; 2011 Jul; 154(1):111-21. PubMed ID: 21554263
[TBL] [Abstract][Full Text] [Related]
2. Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts.
Yang J; Zhang X; Wang J; Qian J; Zhang L; Wang M; Kwak LW; Yi Q
Blood; 2007 Oct; 110(8):3028-35. PubMed ID: 17644731
[TBL] [Abstract][Full Text] [Related]
3. Anti-β₂M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity.
Zhang M; Qian J; Lan Y; Lu Y; Li H; Hong B; Zheng Y; He J; Yang J; Yi Q
Int J Cancer; 2014 Sep; 135(5):1132-41. PubMed ID: 24474467
[TBL] [Abstract][Full Text] [Related]
4. Human-like mouse models for testing the efficacy and safety of anti-beta2-microglobulin monoclonal antibodies to treat myeloma.
Yang J; Cao Y; Hong S; Li H; Qian J; Kwak LW; Yi Q
Clin Cancer Res; 2009 Feb; 15(3):951-9. PubMed ID: 19188166
[TBL] [Abstract][Full Text] [Related]
5. Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies.
Yang J; Qian J; Wezeman M; Wang S; Lin P; Wang M; Yaccoby S; Kwak LW; Barlogie B; Yi Q
Cancer Cell; 2006 Oct; 10(4):295-307. PubMed ID: 17045207
[TBL] [Abstract][Full Text] [Related]
6. Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.
Yang J; Yi Q
Cancer; 2010 Apr; 116(7):1638-45. PubMed ID: 20143445
[TBL] [Abstract][Full Text] [Related]
7. Activation of complement by monoclonal antibodies that target cell-associated β₂-microglobulin: implications for cancer immunotherapy.
Pokrass MJ; Liu MF; Lindorfer MA; Taylor RP
Mol Immunol; 2013 Dec; 56(4):549-60. PubMed ID: 23911412
[TBL] [Abstract][Full Text] [Related]
8. Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy.
Zhang M; He J; Liu Z; Lu Y; Zheng Y; Li H; Xu J; Liu H; Qian J; Orlowski RZ; Kwak LW; Yi Q; Yang J
Oncotarget; 2015 Apr; 6(11):8567-78. PubMed ID: 25895124
[TBL] [Abstract][Full Text] [Related]
9. Induction of strong homotypic adhesion in human T cell lines positive with human T-cell leukemia virus type 1 by monoclonal antibodies to MHC class I and beta 2-microglobulin.
Furuse M; Fukudome K; Imai T; Uwabe K; Hinuma Y; Yoshie O
Cell Immunol; 1992 Sep; 143(2):298-309. PubMed ID: 1380895
[TBL] [Abstract][Full Text] [Related]
10. Changes in rheumatoid factor and monoclonal IgG antibody specificity after site-specific mutations in antigenic region of beta 2-microglobulin.
van Eyndhoven WG; Malone CC; Williams RC
Clin Immunol Immunopathol; 1994 Sep; 72(3):362-72. PubMed ID: 8062449
[TBL] [Abstract][Full Text] [Related]
11. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice.
Palladino G; Mozdzanowska K; Washko G; Gerhard W
J Virol; 1995 Apr; 69(4):2075-81. PubMed ID: 7884853
[TBL] [Abstract][Full Text] [Related]
12. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.
Ciccone E; Pende D; Nanni L; Di Donato C; Viale O; Beretta A; Vitale M; Sivori S; Moretta A; Moretta L
Int Immunol; 1995 Mar; 7(3):393-400. PubMed ID: 7794819
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of β2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cells.
Josson S; Matsuoka Y; Gururajan M; Nomura T; Huang WC; Yang X; Lin JT; Bridgman R; Chu CY; Johnstone PA; Zayzafoon M; Hu P; Zhau H; Berel D; Rogatko A; Chung LW
PLoS One; 2013; 8(7):e68366. PubMed ID: 23874600
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy.
Alhallak K; Sun J; Wasden K; Guenthner N; O'Neal J; Muz B; King J; Kohnen D; Vij R; Achilefu S; DiPersio JF; Azab AK
Leukemia; 2021 Aug; 35(8):2346-2357. PubMed ID: 33479469
[TBL] [Abstract][Full Text] [Related]
15. Extensive CD4 cross-linking inhibits T cell activation by anti-receptor antibody but not by antigen.
Dianzani U; Shaw A; Fernandez-Cabezudo M; Janeway CA
Int Immunol; 1992 Sep; 4(9):995-1001. PubMed ID: 1390442
[TBL] [Abstract][Full Text] [Related]
16. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.
David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW
Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal IgM antibodies from cytomegalovirus-infected mice recognize the GlcNAc-containing receptor determinant of murine CMV as well as neutralizing anti-CMV IgG antibodies.
Ravindranath RM; Graves MC
Virology; 1992 May; 188(1):143-51. PubMed ID: 1373551
[TBL] [Abstract][Full Text] [Related]
18. IgM but not IgG monoclonal anti-Nocardia brasiliensis antibodies confer protection against experimental actinomycetoma in BALB/c mice.
Gonzalez-Suarez ML; Salinas-Carmona MC; Pérez-Rivera I
FEMS Immunol Med Microbiol; 2009 Oct; 57(1):17-24. PubMed ID: 19624737
[TBL] [Abstract][Full Text] [Related]
19. Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia.
Loisel S; André PA; Golay J; Buchegger F; Kadouche J; Cérutti M; Bologna L; Kosinski M; Viertl D; Delaloye AB; Berthou C; Mach JP; Boumsell L
Mol Cancer; 2011 Apr; 10():42. PubMed ID: 21504579
[TBL] [Abstract][Full Text] [Related]
20. CD48 as a novel molecular target for antibody therapy in multiple myeloma.
Hosen N; Ichihara H; Mugitani A; Aoyama Y; Fukuda Y; Kishida S; Matsuoka Y; Nakajima H; Kawakami M; Yamagami T; Fuji S; Tamaki H; Nakao T; Nishida S; Tsuboi A; Iida S; Hino M; Oka Y; Oji Y; Sugiyama H
Br J Haematol; 2012 Jan; 156(2):213-24. PubMed ID: 22098460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
